Navigating the Evolving Treatment Landscape of Diffuse Large B-Cell Lymphoma

被引：23
|
作者：
Nastoupil, Loretta J. [1 ,3 ]
Bartlett, Nancy L. [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Washington Univ, Siteman Canc Ctr, St Louis, MO USA
[3] Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd,Unit 429, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 04期
关键词：
RITUXIMAB PLUS CYCLOPHOSPHAMIDE; PREVIOUSLY UNTREATED PATIENTS; SOUTHWEST-ONCOLOGY-GROUP; NON-HODGKIN-LYMPHOMA; DOUBLE-HIT LYMPHOMA; SINGLE-ARM; OPEN-LABEL; ELDERLY-PATIENTS; PHASE-III; R-CHOP;
D O I：
10.1200/JCO.22.01848
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Diffuse large B-cell lymphoma, the most common subtype of non-Hodgkin lymphoma, comprises a heterogenous group of morphologically, genetically, and clinically distinct diseases. Several recent advances have affected the treatment landscape, which had been mostly stagnant for the past few decades. We will review the practice-changing studies in frontline (POLARIX), early relapse (ZUMA-7 and TRANSFORM), and multiple recurrent (ZUMA-1, JULIET, TRANSCEND, L-MIND, and LOTIS-2) stages and discuss how the treatment landscape may evolve with the emergence of bispecific antibodies.
引用
收藏
页码：903 / +
页数：12
相关论文
共 50 条
  • [31] Current treatment approaches for diffuse large B-cell lymphoma
    Illidge, Tim
    Tolan, Shaun
    LEUKEMIA & LYMPHOMA, 2008, 49 (04) : 663 - 676
  • [32] Novel strategies in the treatment of diffuse large B-cell lymphoma
    Lenz, G.
    ONKOLOGIE, 2012, 35 : 155 - 155
  • [33] Investigational drugs for the treatment of diffuse large B-cell lymphoma
    Patriarca, Andrea
    Gaidano, Gianluca
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (01) : 25 - 38
  • [34] Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma
    Pirosa, Maria Cristina
    Stathis, Anastasios
    Zucca, Emanuele
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [35] Diffuse Large B-cell Lymphoma Diagnosis and Treatment in Kosovo
    Rrusta, Shpat
    Sadiku, Shemsedin
    Ukimeraj, Aferdita
    Berisha, Adriatik
    Gashi, Edlira
    Dakaj, Arbereshe
    Rrusta, Dile
    Berisha, Adriana
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S270 - S270
  • [36] Epigenetic chemosensitization for the treatment of diffuse large B-cell lymphoma
    Telfer, Caroline
    EPIGENOMICS, 2013, 5 (05) : 477 - 477
  • [37] Developments in the treatment of recurrent diffuse large B-cell lymphoma
    von Tresckow, Bastian
    Borchmann, Peter
    ONKOLOGIE, 2025,
  • [38] Diffuse Large B-Cell Lymphoma: Current Treatment Approaches
    Nastoupil, Loretta J.
    Rose, Adam C.
    Flowers, Christopher R.
    ONCOLOGY-NEW YORK, 2012, 26 (05): : 488 - 495
  • [39] Treatment strategies for patients with diffuse large B-cell lymphoma
    Poletto, Stefano
    Novo, Mattia
    Paruzzo, Luca
    Frascione, Pio Manlio Mirko
    Vitolo, Umberto
    CANCER TREATMENT REVIEWS, 2022, 110
  • [40] Time, timing, and the treatment of diffuse large B-cell lymphoma
    Gerds, Aaron T.
    Sekeres, Mikkael A.
    LEUKEMIA & LYMPHOMA, 2016, 57 (02) : 247 - 248
12345